Lv12
74 积分 2021-04-09 加入
Vebreltinib for Advanced Non–Small Cell Lung Cancer Harboring c-Met Exon 14 Skipping Mutation: A Multicenter, Single-Arm, Phase II KUNPENG Study
2小时前
已完结
Savolitinib in patients in China with locally advanced or metastatic treatment-naive non-small-cell lung cancer harbouring MET exon 14 skipping mutations: results from a single-arm, multicohort, multicentre, open-label, phase 3b confirmatory study
2小时前
已完结
Lorlatinib Versus Crizotinib in Patients With Advanced ALK-Positive Non–Small Cell Lung Cancer: 5-Year Outcomes From the Phase III CROWN Study
21小时前
已完结
Amivantamab plus Lazertinib in Previously Untreated EGFR -Mutated Advanced NSCLC
3天前
已完结
Targeted Therapies for Lung Cancer Patients With Oncogenic Driver Molecular Alterations
3天前
已完结
The Effect of Advances in Lung-Cancer Treatment on Population Mortality
3天前
已完结
Refining the treatment of NSCLC according to histological and molecular subtypes
3天前
已完结
Integrated multiomic profiling of breast cancer in the Chinese population reveals patient stratification and therapeutic vulnerabilities
4天前
已完结
Optimising first-line subtyping-based therapy in triple-negative breast cancer (FUTURE-SUPER): a multi-cohort, randomised, phase 2 trial
4天前
已完结
Genetic variation influencing DNA methylation provides insights into molecular mechanisms regulating genomic function
6天前
已完结
皖公网安备34019202002308
